The assessment of antagonist potency under conditions of transient response kinetics

By Christopoulos A.   Parsons A.M.   Lew M.J.   El-Fakahany E.E.  

European Journal of Pharmacology, Vol. 382, Iss. 3, 1999-10 ,pp. : 217-227

Elsevier

Access to resources Recommend Favorite

1 - and 2 -Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines

By Louis S.N.   Nero T.L.   Iakovidis D.   Colagrande F.M.   Jackman G.P.   Louis W.J.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 11, 1999-11 ,pp. : 919-937

Elsevier

Access to resources Recommend Favorite

Facilitation of cognitive functions by a specific 2 -adrenoceptor antagonist, atipamezole

By Haapalinna A.   Sirvio J.   Lammintausta R.  

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 29-40

Elsevier

Access to resources Recommend Favorite

The 2 -adrenoceptor antagonist, (+)-efaroxan, enhances acetylcholine release in the rat cortex in vivo

By Tellez S.   Colpaert F.   Marien M.  

European Journal of Pharmacology, Vol. 277, Iss. 1, 1995-04 ,pp. : 113-116

Elsevier

Access to resources Recommend Favorite

 2-Adrenoceptor Antagonist SL84.0418 Involvement in the Development of Opioid Withdrawal

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 2, 2009-03 ,pp. : 159-162

Bentham Science Publishers

Access to resources Recommend Favorite